InsidersTradesSigma
Follow the IX BIOPHARMA LTD. stock price and the full insider trade history of the company, a listed equity based in Singapore. Shares are listed on the SG market, under the authority of SGX. Market capitalisation: €442.8m. The latest transaction was disclosed on 26 July 2026 (Purchase). Among the most active insiders: Oversea-Chinese Banking Corporation Limited. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
IX Biopharma Ltd. is a company focused on developing pharmaceutical treatments, emphasizing research and innovation in the biopharmaceutical field.